Ana Oaknin
MD, PhD
Head, Gynecological Malignancies Program
👥Biography 个人简介
Ana Oaknin is a gynecologic oncology specialist at Vall d'Hebron with expertise in novel systemic therapies for ovarian and endometrial cancers. She has been a key investigator on trials of mirvetuximab soravtansine in folate receptor alpha-high platinum-resistant ovarian cancer, including SORAYA and MIRASOL. Her research encompasses ADC mechanisms, resistance pathways, and biomarker-based patient selection for gynecologic malignancies. She is an active contributor to ESGO and international gynecologic oncology guidelines.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Ana Oaknin 的研究动态
Follow Ana Oaknin's research updates
留下邮箱，当我们发布与 Ana Oaknin（Vall d'Hebron Institute of Oncology）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment